CGTN Highlights Gut Health's 70% Immune Role as Colorectal Cancer Accounts for 10% of Cases
Updated
Updated · CGTN · May 29
CGTN Highlights Gut Health's 70% Immune Role as Colorectal Cancer Accounts for 10% of Cases
1 articles · Updated · CGTN · May 29
World Digestive Health Day coverage by CGTN said the gut shapes immunity, metabolism and mental well-being, describing it as far more than a digestive organ.
More than 70% of the body's immune cells are concentrated in the intestine, while the gut-brain axis links bowel function with stress, anxiety and sleep disruption.
Unhealthy diets, sedentary habits, smoking, alcohol use, obesity and chronic stress can damage the intestinal environment, while doctors recommend more fruits and vegetables, exercise, weight control and stable sleep.
Colorectal cancer remains a major concern—WHO says it is the third most common cancer and makes up about 10% of all cases—yet doctors note many tumors develop slowly over nearly a decade.
Screening from age 45 for average-risk adults, with earlier monitoring for high-risk groups, can help catch disease early through colonoscopy as well as FOBT and FIT tests.
Are new blood tests for colon cancer making the dreaded colonoscopy obsolete?
Is our gut health crisis caused by bad personal habits or a broken system?
Why is a media outlet accused of propaganda suddenly so focused on your gut health?
Transforming Colorectal Cancer Outcomes by 2026: Microbiome-Based Therapies, Risk Factors, and Early Detection
Overview
This report explores how advances in microbiome-targeted therapies are shaping the future of colorectal cancer (CRC) treatment. It highlights that, as of 2026, new strategies are being developed to use the gut microbiome to both prevent and treat CRC. The 14th GMFH World Summit emphasized the growing role of these interventions in cancer care. A key focus is on how modulating the gut microbiome can enhance the effectiveness of immune checkpoint inhibitors, with evidence showing that certain gut bacteria, like Ruminococcaceae and Akkermansia muciniphila, are linked to better treatment responses across various cancers. These insights are driving innovative approaches in CRC management.